Are you interested in learning about the Food and Drug Administration’s drug approval process? Do you want to better understand how to evaluate the results of clinical trials?
Breast Cancer Action advocates for more effective and less toxic breast cancer treatments by shifting the balance of power in the FDA’s drug approval process away from the powerful pharmaceutical industry.
Join us for the second of BCAction’s free monthly webinar series to find out how to help make sure that the FDA’s standards put public health before private profit. We will focus on how the competing interests of pharmaceutical companies and regulatory governmental bodies can fail to deliver safe and effective drugs that patients need. If you sign up, you will learn about power players at the FDA, the origins of the accelerated approval process, and more.
Title: Patients Before Profits: What You Should Know About the FDA, Big Pharma, and Breast Cancer
Featuring: Miriam Hidalgo, BCAction Volunteer Program Coordinator
Jane Zones, Medical Sociologist and Former BCAction Board Member
a project of Breast Cancer Action
Will an archived copy of the webinar be available for those of us who wee not able to participate today?
thank you.
Joana, we had a technological glitch that made us unable to record the webinar–we’re so sorry about that. We will be sure to let you know if we do another webinar on the subject, and will try to make the information available in other ways. Thank you for your interest and activism.